Study to determine the non inferiority of Group I compared to Group II concerning the efficacy of infliximab with respect to safety and tolerability in patients suffering from chronic plaque psoriasis
Laufzeit: 01.01.2005 - 31.12.2007
Kurzfassung
Klinische Studie zur Behandlung der chronischen Plaque Psoriasis
